Traws Pharma, Inc.
TRAW
$1.68
-$0.34-16.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | -- | 2.73M | 57.00K | 56.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | -- | 2.73M | 57.00K | 56.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 0.00 | -- | 2.73M | 57.00K | 56.00K |
| SG&A Expenses | 2.33M | 1.74M | 1.69M | 2.75M | 3.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.37M | 4.06M | 3.98M | 5.26M | 5.33M |
| Operating Income | -7.37M | -4.06M | -1.25M | -5.20M | -5.28M |
| Income Before Tax | -7.44M | -3.96M | -915.00K | 21.49M | -29.92M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.44M | -3.96M | -915.00K | 21.49M | -29.92M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.44M | -3.96M | -915.00K | 21.49M | -29.92M |
| EBIT | -7.37M | -4.06M | -1.25M | -5.20M | -5.28M |
| EBITDA | -7.32M | -4.04M | -1.25M | -5.20M | -5.28M |
| EPS Basic | -0.58 | -0.34 | -0.11 | 2.17 | -6.96 |
| Normalized Basic EPS | -0.50 | -0.28 | -0.10 | 1.93 | -6.07 |
| EPS Diluted | -0.58 | -0.34 | -0.11 | 2.09 | -6.96 |
| Normalized Diluted EPS | -0.50 | -0.28 | -0.10 | 1.86 | -6.07 |
| Average Basic Shares Outstanding | 9.36M | 8.82M | 5.82M | 6.97M | 3.08M |
| Average Diluted Shares Outstanding | 9.36M | 8.82M | 5.82M | 7.22M | 3.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |